iCAD

Diversity drives everything we do—from our inclusive workforce to how we train our AI. As a US-based company with over 20 years of continuous innovation, iCAD is proud to be the first to deliver leading breast health AI. #ProFoundAI’s algorithm, built on patient cases from diverse backgrounds representative of the US population, empowers doctors to make accurate, personalized decisions for women worldwide. Learn more: https://bit.ly/4dWscNy #iCAD #WhatsNextInAI #BreastAI #CelebrateDiversity #InclusionMatters

Back to School, Back to Health: Schedule Your Mammogram Today! As the kids head back to school, it’s also time to take care of yourself! Scheduling your annual mammogram is essential to helping find any issue while it’s still in its earliest stages. Early detection can make all the difference! But remember, not all mammograms are created equal. Ensure your radiologist is using iCAD’s #ProFoundAI as a second set of eyes when reading your scans. It has been proven to significantly improve their ability to detect cancer earlier. Prioritize yourself this month, in addition to ensuring your kids start another great school year! Your health matters—take that extra step for your family’s peace of mind. https://bit.ly/3M3P8Pf #BackToSchool #EarlyDetection #Mammogram #WomensHealth

[#EmployeeSpotlight] Meet Pam, a Sr. Marketing Manager at iCAD. She is not only a dedicated mother of two amazing girls but also a cancer survivor at the age of 40, having recently marked two years since her personal journey with stage 2 breast cancer. Pam brings her resilience and passion to iCAD, where she oversees and manages the company’s key tradeshow event presence and plays a crucial role in driving strategic commercial initiatives, including webinars, project management, and educational/KOL opportunities. Pam is also an active member of iCAD’s culture committee, helping to usher in the next wave of innovation at iCAD. Her contributions over the past year have significantly elevated iCAD's brand presence and impact on patients and their caregivers. Pam’s collaborative spirit and commitment are evident as she gears up to lead iCAD's presence at #RSNA24, which is expected to draw around 40,000 attendees. Consider Donating to Pam's cause: On November 10th, Pam will be running the #BostonHalfMarathon on behalf of Dana-Farber Cancer Institute to raise money for cancer research. Every contribution helps make a difference: Donate Here https://bit.ly/3YVKJp1 Pam’s journey and professional achievements make her a true inspiration at iCAD as we strive to create a world where cancer can't hide! We're proud to have her on our team—thank you, Pam!

iCAD is creating a world where cancer can’t hide with innovative artificial intelligence (#AI) solutions that empower providers and breast imaging professionals to accurately, reliably, and quickly detect cancer and improve outcomes – optimizing every patient’s opportunity to get the best chances of recovery. Discover our ongoing commitment to creating a world where cancer can’t hide! https://bit.ly/3AqyAhF #ProFoundAI, #iCAD, #BreastAI

iCAD Q2 2024 Earnings Recap: We're excited to highlight our Q2 2024 financial results! Our strong performance highlights the success of our strategic initiatives as we continue to drive growth and innovation in AI-powered breast health solutions. Key Highlights: • ARR: $9.2M, up 7% YoY • Total Revenue: $5M, up 21% YoY • Gross Profit Margin: 84%, up from 81% • GAAP Net Loss: Reduced to ($1.7M) from ($2.3M) YoY Our new ProFound Cloud SaaS platform is exceeding expectations, empowering customers while enhancing our business model. We’re seeing strong interested in our leading ProFound AI Breast Health Suite with 60 perpetual, 29 subscription, and 10 cloud deals closed this quarter! Thank you to our team and partners for making this possible. Together, we’re creating a world where cancer can’t hide. Read more: https://bit.ly/3M4Cy1U

Our customers say it best! See how Cleveland Clinic is recognizing the benefits of AI-enhanced mammography by increasing cancer detection rates while concurrently reducing unnecessary patient recalls. Watch more from this series: https://bit.ly/4fDz3NA #BreastAI, #EarlyDetection, #Mammogram, #iCAD, #ProFoundAI

Have you explored the new #ProFoundAI Detection workstation solution that #radiologists are excited to use? We’re pairing the existing impressive AUC (area under the curve) when detecting breast cancer, with the clinicians’ top requested features to make a great tool even better. Reach out to discuss new upgrade and deployment options to make sure you are getting the best results possible for your imaging center and patients. Explore More: https://bit.ly/3WWotdq #AI, #RadiologyAI, #BreastAI, #Mammography #BreastCancer, #Mammograms

Women are spreading the word… it matters where and how your mammogram screening is done. It just makes sense to choose a breast health clinic who uses state-of-the-art tools paired with a breast-trained radiologist to help keep her as healthy as possible. Risk Evaluation: The risk assessment questions she answers provides her physician guidance on creating a personalized care plan for her screenings. Image Quality: When the Mammography Technologist takes the #mammogram scans, using #intelliMammo helps ensure the scans are as clear as possible so she won’t need to come back in for a rescan. PLUS the imaging center team gathers valuable analytics to help them perform their jobs better and meet regulatory compliance. AI Detection: When the #radiologist reads the scans, #ProFoundAI helps them evaluate any potential areas of suspicion first, greatly increasing the chance of detecting breast cancer at the earliest possible stage, when treatment and outcomes are best. Learn More: https://bit.ly/4dxqmTa CancerIQ, Densitas Inc., iCAD

Ensuring ROI for all your platforms is essential but often daunting to calculate. Positive financial impact paired with clinical and operational improvements is the trifecta we strive to achieve with all our customers. iCAD provides a flexible ROI consultation that uses your imaging center’s data, from patient intake, through various screening modalities, and follow-up visits to calculate various scenarios to meet your needs. Learn more about ROI and other Essentials of an AI-Powered Mammography solution: https://bit.ly/3yvVq6Z

Today iCAD announced results for its fiscal second quarter ended June 30, 2024. “The second quarter of 2024 was highlighted by strong revenue growth of 21%, underscoring the success of our strategic direction as we continue to drive consistent performance,” said Dana Brown, President and CEO of iCAD, Inc. “In line with phase 3 of our transformation plan, this quarter we continued to maximize revenue from our sizeable install base, upgrading customers to new versions including the transition to Cloud, and accelerating deployment across large, national accounts. In the second quarter, we closed 60 perpetual, 29 subscription, and 10 cloud deals with both new and established customers. Our efforts to reduce expenses and grow sales are yielding results. “This was our first full quarter offering our ProFound Cloud SaaS platform and the offering is being received better than expected by both existing and new customers. This solution not only empowers customers but should also create a more predictable and robust economic model for the business over time as it grows as a percentage of revenue.” Read more: https://bit.ly/4dlF543